-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration.

Short-acting beta-agonists (SABAs) are a class of bronchodilators used to treat asthma symptoms quickly. They’re primarily inhaled via a rescue inhaler or a nebulizer. SABA medications work by ...

GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...

Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs. Just nine months after emerging from stealth with a $290 million Series A ...

Swelling or tightness in your throat may be a symptom of asthma, but it could also be due to a co-occurring condition like GERD or vocal cord dysfunction. In some cases, it could signal a severe ...

-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration.

The device, dubbed NPM-115, is a miniature sub-dermal implant that delivers exenatide, a glucagon-like peptide-1 receptor agonist (GLP-1RA). Image credit: Shutterstock / Formatoriginal. A day after ...

When an allergy medication doesn't work anymore—either as well as before or at all—it could be because your body is no longer reacting to the drug in the same way it once did or is clearing it too ...

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...